The present invention provides an engineered bacterium with a high yield of a direct precursor of
oritavancin and its application. The high-yield engineered bacterium is
Amycolatopsis orientalis, which knocks out the potential competitive
biosynthesis pathway of the direct precursor of
oritavancin (Chloroeremomycin) and highly expresses the rate-limiting
enzyme gene of the direct precursor of
oritavancin, thereby obtaining a high-yield bacterium of the direct precursor of oritavancin, and optimizes its
fermentation process to increase the yield of the direct precursor of oritavancin to 3.1 times that of the starting bacterium, reaching 428 mg / L. The present invention combines the application of knocking out potential competitive metabolic pathways, enhancing the expression of rate-limiting enzymes and optimizing the
fermentation process, successfully superimposing multiple high-yield strategies, greatly reducing the production cost of the direct precursor of oritavancin, and improving the
biosynthesis efficiency of the direct precursor of oritavancin. This new strain has important application value in the industrial production of oritavancin.